Filing Details

Accession Number:
0001209191-21-034428
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-20 16:32:56
Reporting Period:
2021-05-18
Accepted Time:
2021-05-20 16:32:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604464 Atara Biotherapeutics Inc. ATRA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553335 Jakob Dupont C/O Atara Bbiotherapeutics, Inc.
611 Gateway Boulevard, Suite 900
South San Francisco CA 94080
Evp, Head Of R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-18 5,184 $14.55 94,945 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.
  2. The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 18, 2021 and May 19, 2021 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.